CAS: 1799328-86-1
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
ASTX660 REF: TM-TQ0029CAS: 1799328-86-1 | 99.08% | 82.00 €~888.00 € | Tue 21 May 24 | |
ASTX 660 REF: 3D-BA166845CAS: 1799328-86-1 | Min. 95% | To inquire | Tue 25 Jun 24 |
ASTX660
CAS:1799328-86-1
ASTX660 is an orally bioavailable dual antagonist of cIAP and XIAP.
Formula:
C30H42FN5O3
Purity:
99.08%
Color and Shape:
Solid
Molecular weight:
539.68
Ref: TM-TQ0029
1mg | 82.00 € | |
5mg | 142.00 € | |
10mg | 212.00 € | |
25mg | 423.00 € | |
50mg | 624.00 € | |
100mg | 888.00 € | |
1ml*10 (DMSO) | 169.00 € |
Estimated delivery in United States, on Tuesday 21 May 2024
ASTX 660
CAS:1799328-86-1
Antagonist of the inhibitor-of-apoptosis-proteins cIAP1/2 and XIAP
Formula:
C30H42FN5O3
Purity:
Min. 95%
Molecular weight:
539.68 g/mol
Ref: 3D-BA166845
1g | To inquire | |
250mg | To inquire | |
500mg | To inquire |
Estimated delivery in United States, on Tuesday 25 Jun 2024